Healthcare provider profile · identity verified

Emily Pfaff, PA

Physician Assistant · FLORENCE, OR · NPI 1467548669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	971	481
Levothyroxine Sodium	Levothyroxine Sodium	768	359
Lisinopril	Lisinopril	540	282
Amlodipine Besylate	Amlodipine Besylate	506	242
Losartan Potassium	Losartan Potassium	462	235
Omeprazole	Omeprazole	419	179
Gabapentin	Gabapentin	334	172
Metoprolol Succinate	Metoprolol Succinate	314	160
Rosuvastatin Calcium	Rosuvastatin Calcium	298	149
Metformin Hcl	Metformin Hcl	293	144
Pantoprazole Sodium	Pantoprazole Sodium	263	112
Hydrochlorothiazide	Hydrochlorothiazide	261	131
Trazodone Hcl	Trazodone Hcl	231	118
Tamsulosin Hcl	Tamsulosin Hcl	203	99
Simvastatin	Simvastatin	202	102
Furosemide	Furosemide	187	101
Albuterol Sulfate Hfa	Albuterol Sulfate	160	82
Eliquis	Apixaban	160	68
Duloxetine Hcl	Duloxetine Hcl	154	62
Sertraline Hcl	Sertraline Hcl	150	68
Carvedilol	Carvedilol	149	69
Metoprolol Tartrate	Metoprolol Tartrate	131	57
Metformin Hcl Er	Metformin Hcl	129	61
Potassium Chloride	Potassium Chloride	124	59
Pravastatin Sodium	Pravastatin Sodium	116	57
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	114	48
Allopurinol	Allopurinol	109	53
Fluoxetine Hcl	Fluoxetine Hcl	108	50
Alendronate Sodium	Alendronate Sodium	103	52
Clopidogrel	Clopidogrel Bisulfate	103	45
Fluticasone Propionate	Fluticasone Propionate	101	52
Citalopram Hbr	Citalopram Hydrobromide	85	44
Escitalopram Oxalate	Escitalopram Oxalate	84	41
Montelukast Sodium	Montelukast Sodium	82	38
Buspirone Hcl	Buspirone Hcl	79	39
Spironolactone	Spironolactone	79	34
Famotidine	Famotidine	77	38
Ezetimibe	Ezetimibe	76	37
Atenolol	Atenolol	73	41
Lovastatin	Lovastatin	72	35
Glipizide Er	Glipizide	68	41
Warfarin Sodium	Warfarin Sodium	68	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	28
Finasteride	Finasteride	65	28
Mirtazapine	Mirtazapine	61	33
Jardiance	Empagliflozin	59	31
Estradiol	Estradiol	57	31
Xarelto	Rivaroxaban	56	25
Synthroid	Levothyroxine Sodium	54	25
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	52	23
Hydroxyzine Hcl	Hydroxyzine Hcl	51	22
Donepezil Hcl	Donepezil Hcl	50	17
Tizanidine Hcl	Tizanidine Hcl	48	22
Bupropion Xl	Bupropion Hcl	46	30
Venlafaxine Hcl Er	Venlafaxine Hcl	46	19
Ozempic	Semaglutide	45	25
Paxlovid	Nirmatrelvir/Ritonavir	45	45
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	23
Quetiapine Fumarate	Quetiapine Fumarate	43	19
Meloxicam	Meloxicam	42	23
Celecoxib	Celecoxib	41	20
Olmesartan Medoxomil	Olmesartan Medoxomil	40	19
Propranolol Hcl	Propranolol Hcl	40	18
Lamotrigine	Lamotrigine	38	14
Prednisone	Prednisone	38	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	18
Glipizide	Glipizide	35	21
Hydralazine Hcl	Hydralazine Hcl	35	19
Oxybutynin Chloride Er	Oxybutynin Chloride	35	14
Paroxetine Hcl	Paroxetine Hcl	35	14
Enalapril Maleate	Enalapril Maleate	34	11
Ropinirole Hcl	Ropinirole Hcl	33	11
Torsemide	Torsemide	33	19
Acyclovir	Acyclovir	32	18
Azelastine Hcl	Azelastine Hcl	32	11
Baclofen	Baclofen	32	17
Ipratropium Bromide	Ipratropium Bromide	32	14
Glimepiride	Glimepiride	31	15
Ketoconazole	Ketoconazole	31	11
Triamcinolone Acetonide	Triamcinolone Acetonide	31	29
Chlorthalidone	Chlorthalidone	30	15
Felodipine Er	Felodipine	30	suppressed
Methocarbamol	Methocarbamol	29	12
Nystatin	Nystatin	29	20
Ondansetron Odt	Ondansetron	29	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	16
Droplet Pen Needle	Pen Needle, Diabetic	26	12
Olanzapine	Olanzapine	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	11
Nortriptyline Hcl	Nortriptyline Hcl	22	13
Hydrocortisone	Hydrocortisone	21	14
Loperamide	Loperamide Hcl	21	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	13
Memantine Hcl	Memantine Hcl	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Valsartan	Valsartan	19	suppressed
Cefdinir	Cefdinir	18	15
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Digoxin	Digoxin	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Topiramate	Topiramate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluconazole	Fluconazole	15	13
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Naproxen	Naproxen	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ramipril	Ramipril	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nyamyc	Nystatin	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error